Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to…
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine…
Jasmine Eyal, Age 16, of Singapore, Receives Top Honors and $400,000 in Education Prizes for her Original Video Explaining Mechanogenetic…
CHICAGO, April 4, 2025 /PRNewswire/ -- In a historic moment, BlackDoctor.org (BDO) inducts its first class into the inaugural TBH…
Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and development for AI cancer models…
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered…
NEW YORK, April 3, 2025 /PRNewswire/ -- The Mark Foundation for Cancer Research convened more than 150 scientists from 13 states…
FORT MYERS, Fla., April 3, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) physicians are participating in…
PARIS and CHICAGO and NASHVILLE, Tenn., April 3, 2025 /PRNewswire/ -- Therapixel, creators of MammoScreen®, a leading artificial intelligence (AI) solution…
WASHINGTON, April 3, 2025 /PRNewswire/ -- The Lilabean Foundation (LBF) is playing a critical role in advancing pediatric brain cancer research…